Pfizer (United States)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2010

  1. Cost-effectiveness analysis of using high doses of atorvastatin for the secondary stroke prevention in Spain

    Revista de Neurologia, Vol. 51, Núm. 1, pp. 1-11